Filing Details

Accession Number:
0001209191-16-132075
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-07-07 18:38:45
Reporting Period:
2016-07-05
Filing Date:
2016-07-07
Accepted Time:
2016-07-07 18:38:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1435049 Aduro Biotech Inc. ADRO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635590 W. Thomas Dubensky C/O Aduro Biotech, Inc.
626 Bancroft Way, 3C
Berkeley CA 94710
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-07-05 13,939 $1.45 13,939 No 4 M Direct
Common Stock Acquisiton 2016-07-05 11,061 $0.52 25,000 No 4 M Direct
Common Stock Disposition 2016-07-05 25,000 $11.61 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2016-07-05 13,939 $0.00 13,939 $1.45
Common Stock Employee Stock Option (right to buy) Disposition 2016-07-05 11,061 $0.00 11,061 $0.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
259,576 2025-01-09 No 4 M Direct
107,191 2021-10-23 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 2, 2016.
  2. The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of January 10, 2015.
  3. The shares subject to the Option were fully vested as of December 31, 2015.